State of Wisconsin Investment Board’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.72M Sell
14,642
-589
-4% -$182K 0.01% 1015
2025
Q4
$4.49M Buy
15,231
+6,198
+69% +$1.15M 0.01% 1047
2025
Q3
$479K Sell
9,033
-5,726
-39% -$278K ﹤0.01% 1919
2025
Q2
$621K Buy
14,759
+148
+1% +$5.64K ﹤0.01% 1765
2025
Q1
$553K Buy
14,611
+3,929
+37% +$245K ﹤0.01% 1715
2024
Q4
$822K Sell
10,682
-1,966
-16% -$142K ﹤0.01% 1602
2024
Q3
$728K Buy
12,648
+698
+6% +$37.7K ﹤0.01% 1692
2024
Q2
$494K Buy
+11,950
New +$565K ﹤0.01% 1832
2022
Q4
Sell
-1,700
Closed -$58K 2619
2022
Q3
$58K Sell
1,700
-1,852
-52% -$92.3K ﹤0.01% 2569
2022
Q2
$131K Sell
3,552
-1,501
-30% -$160K ﹤0.01% 2592
2022
Q1
$774K Buy
5,053
+2,953
+141% +$607K ﹤0.01% 1697
2021
Q4
$621K Hold
2,100
﹤0.01% 1614
2021
Q3
$582K Hold
2,100
﹤0.01% 1647
2021
Q2
$576K Buy
+2,100
New +$752K ﹤0.01% 1648

Other funds holding PRAX

State of Wisconsin Investment Board's PRAX Position: Q1 2026 in Review

State of Wisconsin Investment Board reduced its Praxis Precision Medicines (PRAX) stake by 3.9% in Q1 2026, selling an estimated $182K and leaving 14,642 shares worth $4.72M. The position accounts for 0.01% of the portfolio, ranked #1015.

State of Wisconsin Investment Board first reported a position in PRAX in Q2 2021 and has held it in 14 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • State of Wisconsin Investment Board held 14,642 shares of Praxis Precision Medicines worth $4.72M as of Q1 2026.
  • State of Wisconsin Investment Board sold 589 Praxis Precision Medicines shares in Q1 2026, an estimated $182K.
  • Praxis Precision Medicines made up 0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1015 holding.
  • State of Wisconsin Investment Board first reported a position in Praxis Precision Medicines in Q2 2021 and has held it in 14 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.